Closing remarks

Complement inhibition in medicine: Hematology and beyond; complement inhibition in hematology: PNH and beyond

“…In this manuscript, the authors also highlight the challenges coming from the interaction between academic scientists and for‐profit entities, which eventually drive the development of candidate therapies and shape their actual successful clinical translation. Finally, Prof. Luzzatto in « closing remarks » 8 takes advantage of his long‐lasting contribution to the field to share his vision about current and future complement inhibition in medicine. Indeed, Luzzatto recalls some old and more recent concepts of complement biology and hematological diseases, eventually describing how all these therapeutic achievements have advanced hematology and medicine.…”